Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LGVNLongeveron Inc.

Nasdaq · CIK 0001721484
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts387

Identity from submissions API

NameLongeveron Inc.
CIK0001721484
TickersLGVN
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN472174146
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone305-302-7158
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • LONGEVERON LLC (2017-11-06T05:00:00.000Z → 2021-02-10T05:00:00.000Z)
Business address
1951 NW 7TH AVENUE
SUITE 520
MIAMI
FL
33136
FL
Mailing address
1951 NW 7TH AVENUE
SUITE 520
MIAMI
FL
33136
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

536 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000266 005-92252 261558444 34 13146
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002163771-26-000001 005-92252 261550965 34 6291
2026-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-26-119052 001-40060 261548083 34 298741 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458450 001-40060 261547206 34 9180689 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-123523 005-92252 261529094 34 19409
2026-11-05 8-K CURRENT REPORT 5.02 0001213900-26-116360 001-40060 261527014 34 196594 1 1
2026-10-26 8-K CURRENT REPORT 8.01,9.01 0001213900-26-112508 001-40060 261486440 34 265315 1 1
2026-10-14 8-K CURRENT REPORT 5.02 0001213900-26-109411 001-40060 261459970 34 190297 1 1
2026-10-05 4 PRIMARY DOCUMENT 0001214659-26-012570 5328
2026-10-05 4 PRIMARY DOCUMENT 0001214659-26-012569 5322
2026-10-05 4 PRIMARY DOCUMENT 0001214659-26-012568 5295
2026-10-05 4 PRIMARY DOCUMENT 0001214659-26-012567 5289
2026-10-05 4 PRIMARY DOCUMENT 0001214659-26-012566 5302
2026-09-23 8-K CURRENT REPORT 8.01,9.01 0001213900-26-102611 001-40060 261401026 34 257811 1 1
2026-09-14 8-K CURRENT REPORT 8.01 0001213900-26-099712 001-40060 261377506 34 191744 1 1
2026-09-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000483 005-92252 261371133 34 30329
2026-08-25 4 PRIMARY DOCUMENT 0001214659-26-010852 5121
2026-08-25 3 PRIMARY DOCUMENT 0001214659-26-010851 7920
2026-08-24 8-K CURRENT REPORT 5.03,7.01,9.01 0001213900-26-093028 001-40060 261310689 34 252023 1 1
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010743 5081
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010742 5084
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010741 5635
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010740 5089
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010739 5072
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010736 5109
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010738 5105
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010735 5094
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010737 5105
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010734 5087
2026-08-21 4 PRIMARY DOCUMENT 0001214659-26-010733 5751
2026-08-19 8-K CURRENT REPORT 5.02,9.01 0001213900-26-091677 001-40060 261295338 34 296621 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-088831 005-92252 261270848 34 11582
2026-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-26-088365 001-40060 261267639 34 308285 1 1
2026-08-12 10-Q 10-Q 0001193125-26-346794 001-40060 261267364 34 9110257 1 1
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-093455 005-92252 261259410 34 18856
2026-07-29 8-K CURRENT REPORT 8.01 0001213900-26-082786 001-40060 261217282 34 199731 1 1
2026-07-21 3 PRIMARY DOCUMENT 0001214659-26-008784 8079
2026-07-14 3 PRIMARY DOCUMENT 0001214659-26-008544 7981
2026-07-14 8-K CURRENT REPORT 5.02,9.01 0001213900-26-078019 001-40060 261175055 34 281343 1 1
2026-07-13 3 PRIMARY DOCUMENT 0001214659-26-008493 7988
2026-07-13 3 PRIMARY DOCUMENT 0001214659-26-008492 7985
2026-07-10 S-8 REGISTRATION STATEMENT 0001213900-26-077193 333-297388 261169222 33 212919 1 1
2026-07-08 4 PRIMARY DOCUMENT 0001214659-26-008354 8017
2026-07-08 8-K CURRENT REPORT 5.02 0001213900-26-076359 001-40060 261162460 34 191357 1 1
2026-07-06 4 PRIMARY DOCUMENT 0001214659-26-008254 5158
2026-07-06 4 PRIMARY DOCUMENT 0001214659-26-008253 5145
2026-07-06 4 PRIMARY DOCUMENT 0001214659-26-008252 5131
2026-07-06 4 PRIMARY DOCUMENT 0001214659-26-008251 5138
2026-07-06 4 PRIMARY DOCUMENT 0001214659-26-008250 5125
2026-07-06 8-K CURRENT REPORT 5.02,5.03,5.07,9.01 0001213900-26-075514 001-40060 261156324 34 279819 1 1
2026-06-05 8-K CURRENT REPORT 5.02 0001213900-26-065788 001-40060 261068919 34 195962 1 1
2026-05-20 ARS ARS 0001213900-26-059534 001-40060 261004149 34 748755
2026-05-20 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-059530 001-40060 261004119 34 2843808
2026-05-20 DEF 14A PROXY STATEMENT 0001213900-26-059525 001-40060 261004084 34 6176673 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000129 005-92252 26984386 34 12033
2026-05-13 8-K CURRENT REPORT 2.02,9.01 0001213900-26-055806 001-40060 26973427 34 293927 1 1
2026-05-13 10-Q 10-Q 0001193125-26-221559 001-40060 26973096 34 8028017 1 1
2026-05-08 8-K CURRENT REPORT 8.01,9.01 0001213900-26-053902 001-40060 26958669 34 239923 1 1
2026-05-05 4 PRIMARY DOCUMENT 0001214659-26-005621 5080
2026-05-05 4 PRIMARY DOCUMENT 0001214659-26-005620 5113
2026-05-05 4 PRIMARY DOCUMENT 0001214659-26-005619 5093
2026-05-05 4 PRIMARY DOCUMENT 0001214659-26-005618 5086
2026-05-05 4 PRIMARY DOCUMENT 0001214659-26-005617 5100
2026-05-05 PRE 14A PROXY STATEMENT 0001213900-26-052281 001-40060 26944873 34 6252095 1 1
2026-04-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001244 333-294975 26873232 33 1820
2026-04-17 424B3 PROSPECTUS 0001213900-26-045182 333-294975 26871891 33 325811
2026-04-15 CORRESP filename1.htm 0001213900-26-044030 7483
2026-04-14 UPLOAD filename1.pdf 0000000000-26-003790 333-294975 40090
2026-04-10 8-K CURRENT REPORT 5.02,9.01 0001213900-26-042565 001-40060 26855530 34 207074 1 1
2026-04-10 S-1 REGISTRATION STATEMENT 0001213900-26-042461 333-294975 26854765 33 815099 1 1
2026-04-03 4 PRIMARY DOCUMENT 0001214659-26-004340 5121
2026-04-03 4 PRIMARY DOCUMENT 0001214659-26-004339 5128
2026-04-03 4 PRIMARY DOCUMENT 0001214659-26-004338 5142
2026-04-03 4 PRIMARY DOCUMENT 0001214659-26-004337 5154
2026-04-03 4 PRIMARY DOCUMENT 0001214659-26-004336 5134
2026-03-25 8-K CURRENT REPORT 3.01 0001213900-26-034045 001-40060 26792346 34 207159 1 1
2026-03-25 D xslFormDX01/primary_doc.xml 06b 0001721484-26-000001 021-577617 26789058 33 19494
2026-03-24 8-K CURRENT REPORT 8.01 0001213900-26-033501 001-40060 26786045 34 194088 1 1
2026-03-17 10-K 10-K 0001193125-26-110664 001-40060 26761624 34 13540818 1 1
2026-03-13 4 PRIMARY DOCUMENT 0001214659-26-003290 10548
2026-03-13 3 PRIMARY DOCUMENT 0001214659-26-003289 7825
2026-03-12 8-K CURRENT REPORT 1.01,3.02,5.03,8.01,9.01 0001213900-26-026930 001-40060 26747624 34 1011428 1 1
2026-03-09 8-K CURRENT REPORT 3.01,5.02 0001213900-26-024839 001-40060 26732550 34 193484 1 1
2026-03-03 PRE 14A PROXY STATEMENT 0001213900-26-022706 001-40060 26711087 34 2476500
2026-02-13 8-K CURRENT REPORT 5.02,9.01 0001213900-26-016519 001-40060 26634020 34 319580 1 1
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-005948 005-92252 26615087 34 6776
2026-01-06 4 PRIMARY DOCUMENT 0001214659-26-000206 4990
2026-01-06 4 PRIMARY DOCUMENT 0001214659-26-000205 4986
2026-01-06 4 PRIMARY DOCUMENT 0001214659-26-000204 5004
2026-01-06 4 PRIMARY DOCUMENT 0001214659-26-000203 5000
2026-01-06 4 PRIMARY DOCUMENT 0001214659-26-000202 5021
2025-11-12 8-K CURRENT REPORT 5.02 0001213900-25-108533 001-40060 251468427 34 190931 1 1
2025-11-04 8-K CURRENT REPORT 2.02,9.01 0001213900-25-106117 001-40060 251449256 34 305462 1 1
2025-11-04 10-Q 10-Q 0001193125-25-264604 001-40060 251448781 34 8719468 1 1
2025-10-27 4 PRIMARY DOCUMENT 0001214659-25-015389 4952
2025-10-27 3 PRIMARY DOCUMENT 0001214659-25-015388 7810
2025-10-03 4 PRIMARY DOCUMENT 0001214659-25-014619 4995
2025-10-03 4 PRIMARY DOCUMENT 0001214659-25-014618 5026
2025-10-03 4 PRIMARY DOCUMENT 0001214659-25-014617 4987
2025-10-03 4 PRIMARY DOCUMENT 0001214659-25-014616 5004
2025-10-03 4 PRIMARY DOCUMENT 0001214659-25-014615 5009
2025-10-01 4 PRIMARY DOCUMENT 0001214659-25-014463 7242
2025-10-01 3 PRIMARY DOCUMENT 0001214659-25-014462 8905
2025-10-01 8-K CURRENT REPORT 5.02,9.01 0001213900-25-094710 001-40060 251364999 34 209564 1 1
2025-09-26 8-K CURRENT REPORT 3.01 0001213900-25-092316 001-40060 251350372 34 199117 1 1
2025-09-19 8-K CURRENT REPORT 1.01,9.01 0001213900-25-089595 001-40060 251327413 34 518118 1 1
2025-09-19 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-089589 333-286217 251327352 33 675857
2025-09-03 8-K CURRENT REPORT 5.02,9.01 0001213900-25-084112 001-40060 251290832 34 226727 1 1
2025-08-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-025643 005-92252 251260238 34 6808
2025-08-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-077521 005-92252 251225327 34 20378
2025-08-13 4 PRIMARY DOCUMENT 0001214659-25-012014 7010
2025-08-13 4 PRIMARY DOCUMENT 0001214659-25-012013 6990
2025-08-13 8-K CURRENT REPORT 2.02,9.01 0001213900-25-075679 001-40060 251211681 34 310397 1 1
2025-08-13 10-Q 10-Q 0000950170-25-107983 001-40060 251211281 34 9634936 1 1
2025-08-11 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-074318 001-40060 251202334 34 956687 1 1
2025-08-11 424B4 PROSPECTUS 0001213900-25-073922 333-289210 251200183 33 353068
2025-08-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002544 333-289210 251199939 33 1821
2025-08-08 CORRESP filename1.htm 0001213900-25-073490 5249
2025-08-08 CORRESP filename1.htm 0001213900-25-073488 7398
2025-08-08 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-073401 333-289210 251196754 33 1687704 1 1
2025-08-04 S-1 REGISTRATION STATEMENT 0001213900-25-071302 333-289210 251180101 33 1856765 1 1
2025-07-25 UPLOAD filename1.pdf 0000000000-25-007853 377-08240 40355
2025-07-21 DRS filename1.htm 0001213900-25-066222 377-08240 251138145 33 804696
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010577 5449
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010576 5498
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010575 7207
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010574 4947
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010573 7204
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010572 7221
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010571 7217
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010570 4940
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010569 7245
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010568 4972
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010567 4939
2025-07-17 4 PRIMARY DOCUMENT 0001214659-25-010566 4935
2025-07-09 8-K CURRENT REPORT 8.01,9.01 0001213900-25-062337 001-40060 251113597 34 232252 1 1
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010059 5002
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010061 5006
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010058 5031
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010057 4989
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010060 4992
2025-07-03 4 PRIMARY DOCUMENT 0001214659-25-010056 5423
2025-06-25 4 PRIMARY DOCUMENT 0001214659-25-009623 6660
2025-06-20 S-8 REGISTRATION STATEMENT 0001213900-25-056222 333-288201 251061744 33 218113
2025-06-17 4/A PRIMARY DOCUMENT 0001214659-25-009326 6127
2025-06-17 4 PRIMARY DOCUMENT 0001214659-25-009325 5918
2025-06-16 8-K CURRENT REPORT 5.07,9.01 0001213900-25-054755 001-40060 251049958 34 203081 1 1
2025-06-02 4 PRIMARY DOCUMENT 0001214659-25-008715 7934
2025-05-29 144 xsl144X01/primary_doc.xml 0001968582-25-000421 001-40060 251004998 33 4333
2025-05-27 4 PRIMARY DOCUMENT 0001214659-25-008397 4658
2025-05-16 4 PRIMARY DOCUMENT 0001214659-25-008011 5868
2025-05-15 144 xsl144X01/primary_doc.xml 0002007317-25-000396 001-40060 25951884 33 4338
2025-05-08 8-K CURRENT REPORT 2.02,9.01 0001213900-25-041066 001-40060 25926188 34 293577 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066889 001-40060 25925793 34 8650553 1 1
2025-05-01 8-K CURRENT REPORT 5.02 0001213900-25-037822 001-40060 25898328 34 201576 1 1
2025-04-28 ARS FORM ARS 0001213900-25-036171 001-40060 25881484 34 770763
2025-04-28 DEFA14A ADDITIONAL MATERIALS 0001213900-25-036166 001-40060 25881468 34 1873413
2025-04-28 DEF 14A PROXY STATEMENT 0001213900-25-036161 001-40060 25881447 34 5399363 1 1
2025-04-21 3 PRIMARY DOCUMENT 0001214659-25-006189 7999
2025-04-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000991 333-286217 25816233 33 1820
2025-04-03 4 PRIMARY DOCUMENT 0001214659-25-005400 5003
2025-04-03 4 PRIMARY DOCUMENT 0001214659-25-005399 5017
2025-04-03 4 PRIMARY DOCUMENT 0001214659-25-005398 5042
2025-04-03 4 PRIMARY DOCUMENT 0001214659-25-005397 5000
2025-04-02 CORRESP filename1.htm 0001213900-25-028036 7666
2025-03-31 UPLOAD filename1.pdf 0000000000-25-003440 333-286217 40117
2025-03-28 S-3 REGISTRATION STATEMENT 0001013762-25-004079 333-286217 25785958 33 553775
2025-03-14 8-K CURRENT REPORT 4.01,9.01 0001213900-25-024114 001-40060 25739866 34 239663 1 1
2025-03-06 4 PRIMARY DOCUMENT 0001214659-25-004003 5811
2025-02-28 8-K CURRENT REPORT 2.02,9.01 0001213900-25-018776 001-40060 25690410 34 308265 1 1
2025-02-28 10-K 10-K 0000950170-25-029968 001-40060 25689820 34 12641459 1 1
2025-01-30 8-K CURRENT REPORT 5.02 0001213900-25-008413 001-40060 25574358 34 200001 1 1
2025-01-06 4 PRIMARY DOCUMENT 0001214659-25-000231 5006
2025-01-06 4 PRIMARY DOCUMENT 0001214659-25-000230 5049
2025-01-06 4 PRIMARY DOCUMENT 0001214659-25-000229 5024
2025-01-06 4 PRIMARY DOCUMENT 0001214659-25-000228 5007
2024-12-04 4 PRIMARY DOCUMENT 0001214659-24-019977 5476
2024-11-27 144 xsl144X01/primary_doc.xml 0001959173-24-008257 001-40060 241511961 33 5018
2024-11-14 SC 13G/A armistice-lgvn093024a1.htm 0001172661-24-005229 005-92252 241462759 34 90433
2024-11-12 8-K CURRENT REPORT 2.02,9.01 0001213900-24-096799 001-40060 241448283 34 319501 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125338 001-40060 241447969 34 8759576 1 1
2024-10-03 4 PRIMARY DOCUMENT 0001214659-24-017155 5025
2024-10-03 4 PRIMARY DOCUMENT 0001214659-24-017154 5011
2024-10-03 4 PRIMARY DOCUMENT 0001214659-24-017153 5007
2024-10-03 4 PRIMARY DOCUMENT 0001214659-24-017152 5050
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014995 8880
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014994 8894
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014993 8967
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014992 8911
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014991 7732
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014990 4947
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014989 4942
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014988 5505
2024-08-19 4 PRIMARY DOCUMENT 0001214659-24-014987 5864
2024-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-069029 001-40060 241207996 34 308428 1 1
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068987 001-40060 241207495 34 5421624 1 1
2024-08-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-08-12 16:00:00 9999999995-24-002505 333-281299 241198608 33 1828
2024-08-12 424B3 PROSPECTUS 0001213900-24-067717 333-281299 241197361 33 432311
2024-08-09 CORRESP filename1.htm 0001213900-24-067150 8131
2024-08-08 UPLOAD filename1.pdf 0000000000-24-009096 333-281299 40146
2024-08-07 3 PRIMARY DOCUMENT 0001214659-24-014050 7820
2024-08-07 3 PRIMARY DOCUMENT 0001214659-24-014049 7832
2024-08-07 4 PRIMARY DOCUMENT 0001214659-24-014048 5002
2024-08-07 4 PRIMARY DOCUMENT 0001214659-24-014047 4994
2024-08-06 S-1 REGISTRATION STATEMENT 0001213900-24-065710 333-281299 241180035 33 966289 1 1
2024-07-26 SC 13G SCHEDULE 13G 0001013762-24-001612 005-92252 241147179 34 68441
2024-07-23 D xslFormDX01/primary_doc.xml 06b 0001721484-24-000004 021-519504 241133793 33 19527
2024-07-19 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-24-062766 001-40060 241126147 34 801650 1 1
2024-07-19 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-062763 333-264142 241126121 33 467775
2024-07-17 8-K CURRENT REPORT 8.01,9.01 0001213900-24-061942 001-40060 241121020 34 233180 1 1
2024-07-10 S-8 REGISTRATION STATEMENT 0001213900-24-060540 333-280747 241110460 33 118554
2024-07-10 424B3 PROSPECTUS 0001213900-24-060283 333-280577 241108744 33 294357
2024-07-10 8-K CURRENT REPORT 8.01,9.01 0001213900-24-060281 001-40060 241108711 34 228724 1 1
2024-07-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-07-09 17:00:00 9999999995-24-002109 333-280577 241108600 33 1828
2024-07-05 CORRESP filename1.htm 0001213900-24-059573 14192
2024-07-03 4 PRIMARY DOCUMENT 0001214659-24-011986 4688
2024-07-03 8-K CURRENT REPORT 5.07,9.01 0001213900-24-059046 001-40060 241100307 34 208598 1 1
2024-07-03 UPLOAD filename1.pdf 0000000000-24-007600 333-280577 40131
2024-06-28 S-1 REGISTRATION STATEMENT 0001213900-24-057196 333-280577 241085976 33 633981 1 1
2024-06-25 D xslFormDX01/primary_doc.xml 06b 0001721484-24-000003 021-516862 241068034 33 18688
2024-06-18 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-24-053828 001-40060 241052281 34 611994 1 1
2024-06-11 4 PRIMARY DOCUMENT 0001214659-24-010840 4858
2024-06-07 4 PRIMARY DOCUMENT 0001214659-24-010719 5007
2024-05-22 424B3 PROSPECTUS 0001213900-24-045991 333-278995 24974503 33 329715
2024-05-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-21 17:00:00 9999999995-24-001600 333-278995 24971550 33 1827
2024-05-21 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-045580 333-278995 24969415 33 604383 1 1
2024-05-20 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-045204 001-40060 24964782 34 1685283
2024-05-20 DEF 14A PROXY STATEMENT 0001213900-24-045202 001-40060 24964763 34 3316406
2024-05-20 ARS FORM ARS 0001213900-24-045176 001-40060 24964511 34 943560
2024-05-17 CORRESP filename1.htm 0001213900-24-044771 8253
2024-05-14 4 PRIMARY DOCUMENT 0001214659-24-009103 4937
2024-05-14 3 PRIMARY DOCUMENT 0001214659-24-009102 7997
2024-05-14 10-Q QUARTERLY REPORT 0001213900-24-042909 001-40060 24944099 34 4669787 1 1
2024-05-10 8-K CURRENT REPORT 3.01,5.02,9.01 0001213900-24-041753 001-40060 24935394 34 255794 1 1
2024-05-06 4 PRIMARY DOCUMENT 0001214659-24-008445 4859
2024-05-06 4 PRIMARY DOCUMENT 0001214659-24-008444 4845
2024-05-06 UPLOAD filename1.pdf 0000000000-24-005145 333-278995 40319
2024-04-30 S-1 REGISTRATION STATEMENT 0001213900-24-037313 333-278995 24893081 33 635036 1 1
2024-04-25 D xslFormDX01/primary_doc.xml 06b 0001721484-24-000002 021-511579 24874598 33 19397
2024-04-18 8-K CURRENT REPORT 1.01,3.02,7.01,8.01,9.01 0001213900-24-034129 001-40060 24854672 34 614807 1 1
2024-04-17 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-17 16:14:00 9999999995-24-001002 333-276745 24852687 33 1827
2024-04-17 424B4 PROSPECTUS 0001213900-24-033861 333-276745 24851898 33 396666
2024-04-17 SC 13G SCHEDULE 13G 0001213900-24-033791 005-92252 24850966 34 94763
2024-04-16 CORRESP filename1.htm 0001213900-24-033518 8230
2024-04-16 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-033507 333-276745 24848577 33 757089 1 1
2024-04-15 SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 0001213900-24-032946 005-92252 24844601 34 41442
2024-04-12 4 PRIMARY DOCUMENT 0001214659-24-006773 11504
2024-04-12 4 PRIMARY DOCUMENT 0001214659-24-006772 6857
2024-04-12 4 PRIMARY DOCUMENT 0001214659-24-006771 11013
2024-04-11 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-24-032239 001-40060 24839250 34 968267 1 1
2024-04-10 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-031783 333-275578 24834548 33 47533
2024-04-10 424B4 PROSPECTUS 0001213900-24-031732 333-278073 24834273 33 789794
2024-04-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-08 14:00:00 9999999995-24-000891 333-278073 24831041 33 1827
2024-04-08 CORRESP filename1.htm 0001213900-24-031085 5780
2024-04-08 CORRESP filename1.htm 0001213900-24-031083 7403
2024-04-08 FWP FREE WRITING PROSPECTUS 0001213900-24-030989 333-278073 24828250 34 38602
2024-04-05 S-1/A REGISTRATION STATEMENT 0001213900-24-030874 333-278073 24827417 33 1545727 1 1
2024-04-03 S-1/A REGISTRATION STATEMENT 0001213900-24-029926 333-278073 24820114 33 2241637 1 1
2024-03-27 UPLOAD filename1.pdf 0000000000-24-003319 333-278073 40319
2024-03-20 4 PRIMARY DOCUMENT 0001214659-24-004897 6458
2024-03-19 S-1 REGISTRATION STATEMENT 0001213900-24-024093 333-278073 24764929 33 1528799 1 1
2024-03-19 8-K CURRENT REPORT 5.03,7.01,9.01 0001213900-24-024003 001-40060 24762896 34 265900 1 1
2024-03-11 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-24-021391 001-40060 24737912 34 594684 1 1
2024-03-07 8-K CURRENT REPORT 3.01 0001213900-24-020524 001-40060 24727300 34 205027 1 1
2024-03-01 CORRESP filename1.htm 0001213900-24-018985 7424
2024-02-27 10-K ANNUAL REPORT 0001213900-24-017521 001-40060 24686518 34 19115530 1 1
2024-02-22 8-K CURRENT REPORT 5.07 0001213900-24-016121 001-40060 24664591 34 203543 1 1
2024-02-14 SC 13G armistice-lgvn123123.htm 0001172661-24-001373 005-92252 24637026 34 90410
2024-02-09 UPLOAD filename1.pdf 0000000000-24-001560 333-276745 43897
2024-02-05 DEF 14A PROXY STATEMENT 0001213900-24-010087 001-40060 24596490 34 2469522
2024-02-02 4 PRIMARY DOCUMENT 0001214659-24-001811 5355
2024-01-29 S-1 REGISTRATION STATEMENT 0001213900-24-007380 333-276745 24573622 33 1103855 1 1
2024-01-25 4 PRIMARY DOCUMENT 0001214659-24-001204 5015
2024-01-25 4 PRIMARY DOCUMENT 0001214659-24-001203 5038
2024-01-25 4 PRIMARY DOCUMENT 0001214659-24-001201 4998
2024-01-25 4 PRIMARY DOCUMENT 0001214659-24-001202 5001
2024-01-25 PRE 14A PROXY STATEMENT 0001213900-24-006529 001-40060 24563200 34 2444630
2024-01-11 4 PRIMARY DOCUMENT 0001214659-24-000652 5165
2024-01-08 D xslFormDX01/primary_doc.xml 06b 0001721484-24-000001 021-501798 24519000 33 19390
2024-01-02 4 PRIMARY DOCUMENT 0001214659-24-000079 6663
2023-12-29 4 PRIMARY DOCUMENT 0001214659-23-017126 4547
2023-12-28 8-K CURRENT REPORT 5.07 0001213900-23-099229 001-40060 231522723 34 214845 1 1
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016877 5436
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016876 5463
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016875 5445
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016874 5446
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016878 5443
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016873 5443
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016872 5451
2023-12-26 4 PRIMARY DOCUMENT 0001214659-23-016871 5334
2023-12-22 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-23-097862 001-40060 231507284 34 796512 1 1
2023-12-22 424B5 PROSPECTUS SUPPLEMENT 0001213900-23-097858 333-264142 231507232 33 369193
2023-12-18 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-23-096529 005-92252 231494298 34 62806
2023-12-06 424B3 PROSPECTUS 0001213900-23-093663 333-275578 231469658 33 246979
2023-11-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-21 16:15:00 9999999995-23-003415 333-275578 231429875 33 1779
2023-11-17 CORRESP filename1.htm 0001213900-23-088269 8580
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012576 40325
2023-11-15 S-1 REGISTRATION STATEMENT 0001213900-23-087605 333-275578 231411286 33 552128 1 1
2023-11-14 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-086262 001-40060 231400394 34 1816423
2023-11-14 DEF 14A PROXY STATEMENT 0001213900-23-086261 001-40060 231400361 34 2412590
2023-11-09 10-Q QUARTERLY REPORT 0001213900-23-085194 001-40060 231392150 34 5221237 1 1
2023-11-02 PRE 14A PROXY STATEMENT 0001213900-23-082768 001-40060 231372184 34 2337556
2023-10-24 D xslFormDX01/primary_doc.xml 06b 0001721484-23-000001 021-495525 231342456 33 19385
2023-10-13 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001013762-23-003640 001-40060 231323947 34 964690 1 1
2023-10-13 424B5 PROSPECTUS 0001013762-23-003627 333-264142 231323746 33 676138
2023-10-05 8-K CURRENT REPORT 8.01,9.01 0001013762-23-002000 001-40060 231309832 34 5648194 1 1
2023-10-04 4 PRIMARY DOCUMENT 0001214659-23-013144 4917
2023-10-04 4 PRIMARY DOCUMENT 0001214659-23-013143 4915
2023-10-04 4 PRIMARY DOCUMENT 0001214659-23-013142 4900
2023-09-25 8-K CURRENT REPORT 8.01 0001213900-23-079136 001-40060 231275835 34 244025 1 1
2023-09-22 4 PRIMARY DOCUMENT 0001214659-23-012594 8165
2023-09-21 4 PRIMARY DOCUMENT 0001214659-23-012553 7634
2023-09-21 25-NSE xslF25X02/primary_doc.xml 0001354457-23-000691 001-40060 231269193 34 2990
2023-09-14 4 PRIMARY DOCUMENT 0001214659-23-012361 8171
2023-09-13 4 PRIMARY DOCUMENT 0001214659-23-012330 9678
2023-09-13 4 PRIMARY DOCUMENT 0001214659-23-012323 22901
2023-09-13 4 PRIMARY DOCUMENT 0001214659-23-012322 16726
2023-09-12 4 PRIMARY DOCUMENT 0001214659-23-012293 8056
2023-09-06 4 PRIMARY DOCUMENT 0001214659-23-012145 4939
2023-08-22 4 PRIMARY DOCUMENT 0001214659-23-011605 4779
2023-08-22 4 PRIMARY DOCUMENT 0001214659-23-011606 4901
2023-08-22 4 PRIMARY DOCUMENT 0001214659-23-011604 4939
2023-08-18 8-K CURRENT REPORT 1.01,9.01 0001213900-23-068990 001-40060 231186298 34 515893 1 1
2023-08-16 8-K CURRENT REPORT 8.01,9.01 0001213900-23-068309 001-40060 231179159 34 294367 1 1
2023-08-16 CERT LGVNV_8-A_Cert.pdf 0001354457-23-000586 001-40060 231177542 34 237310
2023-08-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-08-14 16:15:00 9999999995-23-002378 333-272946 231173073 33 1779
2023-08-14 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-23-067182 001-40060 231171608 34 20982
2023-08-14 424B3 PROSPECTUS 0001213900-23-067166 333-272946 231171426 33 1167145
2023-08-14 8-K CURRENT REPORT 8.01,9.01 0001213900-23-067108 001-40060 231170895 34 227120 1 1
2023-08-11 CORRESP filename1.htm 0001213900-23-066307 8504
2023-08-11 S-1/A REGISTRATION STATEMENT 0001213900-23-066272 333-272946 231164620 33 1941983 1 1
2023-08-11 10-Q QUARTERLY REPORT 0001213900-23-065909 001-40060 231161731 34 4973721 1 1
2023-08-02 4 PRIMARY DOCUMENT 0001214659-23-010672 4949
2023-08-02 3 PRIMARY DOCUMENT 0001214659-23-010671 7895
2023-08-02 4 PRIMARY DOCUMENT 0001214659-23-010670 4937
2023-07-28 S-1/A REGISTRATION STATEMENT 0001213900-23-060847 333-272946 231123980 33 2414951 1 1
2023-07-28 CORRESP filename1.htm 0001213900-23-060822 10060
2023-07-20 8-K CURRENT REPORT 5.02,9.01 0001213900-23-058324 001-40060 231098151 34 236943 1 1
2023-07-17 4 PRIMARY DOCUMENT 0001214659-23-009703 4939
2023-07-13 3 PRIMARY DOCUMENT 0001214659-23-009596 7958
2023-07-11 UPLOAD filename1.pdf 0000000000-23-007343 44679
2023-07-05 8-K CURRENT REPORT 5.02,9.01 0001213900-23-054758 001-40060 231068765 34 203550 1 1
2023-06-29 4 PRIMARY DOCUMENT 0001214659-23-008993 8500
2023-06-27 S-1 REGISTRATION STATEMENT 0001213900-23-051787 333-272946 231043776 33 1766372 1 1
2023-06-26 S-8 REGISTRATION STATEMENT 0001213900-23-051730 333-272938 231042840 33 139440
2023-06-23 8-K CURRENT REPORT 7.01,9.01 0001213900-23-051125 001-40060 231034890 34 13921697 1 1
2023-06-12 4 PRIMARY DOCUMENT 0001214659-23-008429 4777
2023-06-12 4 PRIMARY DOCUMENT 0001214659-23-008428 4855
2023-06-12 4 PRIMARY DOCUMENT 0001214659-23-008427 4740
2023-06-12 3 PRIMARY DOCUMENT 0001214659-23-008424 7738
2023-06-12 3 PRIMARY DOCUMENT 0001214659-23-008423 7906
2023-06-12 8-K CURRENT REPORT 5.07,9.01 0001213900-23-048139 001-40060 231007981 34 208559 1 1
2023-06-09 4 PRIMARY DOCUMENT 0001214659-23-008396 4780
2023-06-09 4 PRIMARY DOCUMENT 0001214659-23-008395 4778
2023-06-05 8-K CURRENT REPORT 5.02,9.01 0001213900-23-046224 001-40060 23993400 34 200970 1 1
2023-05-12 10-Q QUARTERLY REPORT 0001213900-23-039003 001-40060 23915637 34 4661619 1 1
2023-05-12 8-K CURRENT REPORT 2.02,9.01 0001213900-23-038758 001-40060 23913543 34 325686 1 1
2023-04-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-033890 001-40060 23866283 34 1695006
2023-04-28 ARS ANNUAL REPORT 0001213900-23-033887 001-40060 23866213 34 757507
2023-04-28 DEF 14A PROXY STATEMENT 0001213900-23-033867 001-40060 23865896 34 3129219
2023-04-10 8-K CURRENT REPORT 5.02 0001213900-23-028583 001-40060 23811169 34 199217 1 1
2023-04-05 4 PRIMARY DOCUMENT 0001214659-23-004988 4778
2023-04-05 4 PRIMARY DOCUMENT 0001214659-23-004987 4776
2023-03-14 10-K ANNUAL REPORT 0001213900-23-020006 001-40060 23732078 34 6674012 1 1
2023-03-10 8-K CURRENT REPORT 2.02,9.01 0001213900-23-019022 001-40060 23721963 34 284653 1 1
2023-03-02 4 PRIMARY DOCUMENT 0001214659-23-003461 4900
2023-03-02 3 PRIMARY DOCUMENT 0001214659-23-003457 7895
2023-02-28 8-K CURRENT REPORT 5.02,9.01 0001213900-23-015114 001-40060 23680226 34 304893 1 1
2023-01-30 4 PRIMARY DOCUMENT 0001214659-23-001282 6573
2023-01-27 8-K CURRENT REPORT 5.02 0001213900-23-005651 001-40060 23562690 34 198289 1 1
2023-01-17 5 PRIMARY DOCUMENT 0001214659-23-000715 4707
2023-01-06 8-K CURRENT REPORT 7.01,9.01 0001213900-23-001264 001-40060 23514181 34 244720 1 1
2023-01-04 4 PRIMARY DOCUMENT 0001214659-23-000206 4747
2023-01-04 4 PRIMARY DOCUMENT 0001214659-23-000205 4745
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015257 5328
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015256 5326
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015255 5328
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015254 5326
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015253 5346
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015252 5319
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015251 5329
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015250 5336
2022-12-22 4 PRIMARY DOCUMENT 0001214659-22-015249 5358
2022-12-05 4 PRIMARY DOCUMENT 0001214659-22-014532 6574
2022-11-18 4 PRIMARY DOCUMENT 0001214659-22-014018 5372
2022-11-18 4 PRIMARY DOCUMENT 0001214659-22-014017 6103
2022-11-14 10-Q QUARTERLY REPORT 0001213900-22-072161 001-40060 221384918 34 4935029 1 1
2022-11-14 8-K CURRENT REPORT 2.02,9.01 0001213900-22-071704 001-40060 221381084 34 313487 1 1
2022-11-03 8-K CURRENT REPORT 5.02 0001213900-22-069048 001-40060 221358998 34 199429 1 1
2022-10-18 4 PRIMARY DOCUMENT 0001214659-22-012423 5977
2022-10-05 4 PRIMARY DOCUMENT 0001214659-22-012063 4746
2022-10-05 4 PRIMARY DOCUMENT 0001214659-22-012062 4748
2022-09-01 8-K CURRENT REPORT 7.01,9.01 0001213900-22-053081 001-40060 221220398 34 273753 1 1
2022-08-12 10-Q QUARTERLY REPORT 0001213900-22-047372 001-40060 221159859 34 4970096 1 1
2022-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-22-047098 001-40060 221158154 34 378643 1 1
2022-07-05 4 PRIMARY DOCUMENT 0001214659-22-008624 4746
2022-07-05 4 PRIMARY DOCUMENT 0001214659-22-008626 4748
2022-06-27 8-K CURRENT REPORT 5.07 0001213900-22-035177 001-40060 221044488 34 202636 1 1
2022-06-07 4 PRIMARY DOCUMENT 0001214659-22-007878 6932
2022-06-07 4 PRIMARY DOCUMENT 0001214659-22-007877 6557

Latest XBRL company facts

One latest value per concept from companyfacts (387 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 16.49M 2025-06-30 2025 FY 10-K 2026-03-17 0001193125-26-110664
ffd NetFeeAmt NetFeeAmt USD 448.82 2026-07-10 S-8 2026-07-10 0001213900-26-077193
ffd TtlFeeAmt TtlFeeAmt USD 448.82 2026-07-10 S-8 2026-07-10 0001213900-26-077193
ffd TtlOfferingAmt TtlOfferingAmt USD 3.25M 2026-07-10 S-8 2026-07-10 0001213900-26-077193
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-10 S-8 2026-07-10 0001213900-26-077193
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-09 S-1 2026-04-10 0001213900-26-042461
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 200,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 64,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 20,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 207,000 2022-11-16 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 52,500 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 6.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment USD 500,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 100,000 2014-11-20 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 153.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 0 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264604
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 853,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 207,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 500,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 1.10M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap Assets Assets USD 12.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap AssetsCurrent Assets, Current USD 8.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 33,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346794
us-gaap Cash Cash USD 15.30M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 9.96M 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.001 2023-10-11 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 2.57M 2024-08-06 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap CommonStockSharesHeldInEmployeeTrustShares Common Stock, Shares Held in Employee Trust, Shares shares 10,627 2022-01-05 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 100,000 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042461
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -17.26M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264604
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-221559
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 40,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 2.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap CostOfRevenue Cost of Revenue USD 283,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap CostsAndExpenses Costs and Expenses USD 200,000 2023-03-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap CumulativeEarningsDeficit Cumulative Earnings (Deficit) USD 58.30M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 8.84M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 43.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 40.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 1.90M 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039003
us-gaap DebtCurrent Debt, Current USD 5,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 731 2021-07-20 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 300,390 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 250,000 2016-12-23 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.054 2020-09-01 2020-09-27 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 6,499 2020-09-01 2020-09-27 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 171,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap DeferredCompensationArrangementWithIndividualCompensationExpense Deferred Compensation Arrangement with Individual, Compensation Expense USD 15,000 2023-01-03 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 47,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 8.74M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap DeferredRevenue Deferred Revenue USD 0 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 826,000 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap DeferredRevenueRefundPayments1 Deferred Revenue, Refund Payments USD 400,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap DeferredTaxAssetsFrequentFlierLiability Deferred Tax Assets, Frequent Flier Liability USD 2,000 2022-07-01 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 183,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 23.40M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 4.84M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 47,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 15.30M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 61.40M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 55.40M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 606,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.99M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Severance Payments USD 275,000 2023-04-19 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 283,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 911,000 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 23.35M 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 1.75M 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 14.00M 2022-01-05 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap Depreciation Depreciation USD 500,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap DepreciationAmortizationAndAccretionNet Depreciation, Amortization and Accretion, Net USD 710,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 699,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax Discontinued Operation, Provision for Loss (Gain) on Disposal, Net of Tax USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.9 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -5.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.182 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.5 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.038 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.62M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 500,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap EmployeeStockOwnershipPlanESOPDividendsPaidToESOP Employee Stock Ownership Plan (ESOP), Dividends Paid to ESOP USD 75,000 2023-09-28 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap EquipmentExpense Equipment Expense USD 17,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 800,000 2023-08-16 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 2.19M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 37,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 126,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 3.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 300,000 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -97,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -170,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -97,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 303,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 9.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 218,000 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap GrossProfit Gross Profit USD 517,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -10.28M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap IncomeTaxesPaid Income Taxes Paid USD 106.00M 2022-01-01 2022-01-05 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 222,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 403,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -851,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 346,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 10,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346794
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -391,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD -1.40M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -170,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -330,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 154,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD 63,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 500,000 2016-12-23 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 800,000 2021-03-03 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 2.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap InterestExpense Interest Expense USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap InterestExpenseDebt Interest Expense, Debt USD 4,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation Investment Company, Distributable Earnings (Loss), Accumulated Appreciation (Depreciation) USD 85,000 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap InvestmentCompanyExcessExpenseReimbursable InvestmentCompanyExcessExpenseReimbursable USD 21,307 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 170,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap LeaseCost Lease, Cost USD 500,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264604
us-gaap LegalFees Legal Fees USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap LesseeFinanceLeaseDiscountRate Lessee, Finance Lease, Discount Rate pure 0.05 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.05 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 419,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 185,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 224,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 169,000 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 169,000 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 170,000 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 179,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 10,000 2020-07-01 2023 Q1 10-Q 2023-05-12 0001213900-23-039003
us-gaap Liabilities Liabilities USD 7.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 12.02M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 778,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap LifeInsuranceCorporateOrBankOwnedAmount Life Insurance, Corporate or Bank Owned, Amount USD 1.22M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap LifeSettlementContractsFairValueMethodCarryingAmount Life Settlement Contracts, Fair Value USD 1.40M 2022-07-12 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 1.40M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 1.40M 2021-09-13 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap LoansPayableCurrent Loans Payable, Current USD 586,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap LongTermDebt Long-term Debt USD 311,000 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five USD 3,000 2020-12-31 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four USD 3,000 2020-12-31 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three USD 3,000 2020-12-31 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two USD 3,000 2020-12-31 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD 1,000 2020-12-31 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap MarketableSecurities Marketable Securities USD 5.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066889
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -179,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 2.83M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap MembersEquity Members' Equity USD 1.96M 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 847,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -189,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -12.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -16.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -22.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 290,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 30.00M 2023-06-01 2023-06-27 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingExpenses Operating Expenses USD 18.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -18.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseCost Operating Lease, Cost USD 711,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 412,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 412,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeasePayments Operating Lease, Payments USD 851,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 246,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.70M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.39M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 171,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 169,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 682,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 682,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 682,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OperatingLeasesIncomeStatementSubleaseRevenue Operating Leases, Income Statement, Sublease Revenue USD 10,000 2020-07-01 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.05 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 207,000 2022-11-16 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 100,000 2023-12-31 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap OtherAssets Other Assets USD 197,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherCashEquivalentsAtCarryingValue Other Cash Equivalents, at Carrying Value USD 50,000 2014-11-20 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear Other Commitment, to be Paid, Remainder of Fiscal Year USD 35,000 2023-09-28 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264604
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax USD -58,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039003
us-gaap OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodBeforeTax Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Unrealized Gain (Loss) Arising During Period, before Tax USD 7,000 2023-04-03 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 200,000 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap OtherExpenses Other Expenses USD 265,000 2014-11-20 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 100,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap OtherIncome Other Income USD 204,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherNoncashExpense Other Noncash Expense USD 1.40M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap OtherNonrecurringExpense Other Nonrecurring Expense USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 204,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OtherRecurringIncome Other Recurring Income USD 15.40M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap OtherShortTermInvestments Other Short-term Investments USD 5.91M 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap PartnersCapitalAccountUnitsSoldInPrivatePlacement Partners' Capital Account, Units, Sold in Private Placement shares 1.17M 2021-12-01 2021-12-03 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -591,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap PaymentsForRent Payments for Rent USD 22,500 2022-07-01 2022-07-22 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 37,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 798,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 4.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 840,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PrepaidTaxes Prepaid Taxes USD 106,000 2022-01-03 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 18.50M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan Proceeds from Issuance of Common Stock, Dividend Reinvestment Plan USD 8.50M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 1.10M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 450,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.34M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ProceedsFromLifeInsurancePolicies Proceeds from Life Insurance Policy USD 63,000 2020-09-01 2020-09-27 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 63,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -38,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 60,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 7.06M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 98,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ProductLiabilityContingencyAccrualPresentValue Product Liability Contingency, Accrual, Present Value USD 2.19M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ProfessionalFees Professional Fees USD 27,000 2016-12-23 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -3.51M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 7.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 6.01M 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-221559
us-gaap RegistrationPaymentArrangementAccrualCarryingValue Registration Payment Arrangement, Accrual Carrying Value USD 500,000 2014-11-20 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 38,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042461
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 150,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 38,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 330,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 172,274 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -149.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD -85.00M 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 455,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap Revenues Revenues USD 548,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap RevenuesNetOfInterestExpense Revenues, Net of Interest Expense USD 646,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap RoyaltyExpense Royalty Expense USD 10,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 350,000 2022-04-04 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 26.13M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.36M 2023-12-22 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SecurityDeposit Security Deposit USD 10,000 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 783,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SeveranceCosts1 Severance Costs USD 275,000 2023-04-19 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 200,000 2023-03-01 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2022-12-01 2022-12-21 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 109,769 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 130,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 11,239 2023-12-31 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 227,030 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 3.23 2023-03-01 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.95 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.95 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate pure 0.3 2022-04-04 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 374 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 76,199 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 50,000 2023-03-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 402,036 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 40,000 2022-04-04 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 50,000 2022-04-04 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.96 2022-03-31 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 139,223 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 88,625 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 96,000 2023-12-21 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) shares 196,751 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 43,782 2023-12-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 6.04 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.125 2024-07-17 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 122,947 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 6,690 2023-04-01 2023-04-19 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.05 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125338
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 11.34 2022-04-04 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.73 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 8.63 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.62 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 3 2022-12-21 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 1 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased Shares Held in Employee Stock Option Plan, Committed-to-be-Released shares 18,002 2022-07-01 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap SharesIssued Shares, Issued shares 820 2019-11-22 2022 Q1 10-Q 2022-05-13 0001213900-22-026433
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 2.61 2023-04-03 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 52,227 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 457,000 2023-03-31 2023 Q1 10-Q 2023-05-12 0001213900-23-039003
us-gaap ShortTermBorrowings Short-term Debt USD 19,000 2021-03-31 2021 Q1 10-Q 2021-05-14 0001213900-21-026411
us-gaap ShortTermInvestments Short-term Investments USD 8.70M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 16,113 2021-02-01 2021-02-28 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap StockholdersEquityOtherShares Stockholders' Equity, Other Shares shares 704,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap StockIssued1 Stock Issued USD 777,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 380,968 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 575,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 5.34M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.14M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 100,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068987
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001213900-23-020006
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD -153,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 2.35 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0001213900-24-042909
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 2.61 2023-04-03 2023 Q2 10-Q 2023-08-11 0001213900-23-065909
us-gaap SubleaseIncome Sublease Income USD 27,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-27 0001213900-24-017521
us-gaap SubsequentEventEffectOfChangeInTaxStatus Subsequent Event, Effect of Change in Tax Status USD 489,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058657
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 26,000 2022-07-01 2022 Q3 10-Q 2022-11-14 0001213900-22-072161
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD -17,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066889
us-gaap TradingSecuritiesDebtAmortizedCost Debt Securities, Trading, Amortized Cost USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029968
us-gaap TreasuryStockValue Treasury Stock, Value USD 100,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap UnrealizedGainLossOnHybridInstrumentNet Unrealized Gain (Loss) on Hybrid Instrument, Net USD 48,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066889
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap USGovernmentAgenciesSecuritiesAtCarryingValue US Government Agencies Securities, at Carrying Value USD 751,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 5.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-17 0001193125-26-110664
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 5.25 2023-08-16 2023 Q3 10-Q 2023-11-09 0001213900-23-085194
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 3.9 2024-07-19 2025 Q2 10-Q 2025-08-13 0000950170-25-107983
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 18.92M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001213900-22-011894
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458450

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →